The dimorphic effects of TGF-β, particulary that early inhibition exacerbates TAA formation, provides an increased rationale for this study to identify new biomarkers and therapies independent of the TGF-β signaling pathway, such as KLF4, to better understand the early developmental changes in Marfan’s Syndrome. The gene discussed is KLF4; the disease is Marfan syndrome.